Stay updated on Pembrolizumab in Medullary Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Medullary Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Medullary Thyroid Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page's revision tag changed from v3.6.2 to v3.6.3, indicating a new build/version of the page.
    Difference
    0.0%
    Check dated 2026-07-04T04:18:37.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.6.0 to v3.6.2, indicating a site version update with no changes to the study details or page content.
    Difference
    0.0%
    Check dated 2026-06-27T02:52:04.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Enrollment status updated to 'No longer looking for participants' indicates the study is no longer enrolling. The update also adds new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study), standardizes the Intervention/Treatment label, and updates the UI version to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T16:57:29.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page's revision tag changed from v3.5.4 to v3.5.5, reflecting a minor update to the page version history. No substantive content changes are indicated.
    Difference
    0.1%
    Check dated 2026-06-05T17:42:20.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.3 to v3.5.4, indicating a minor update to the page or its underlying system.
    Difference
    0.1%
    Check dated 2026-05-15T05:43:33.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page’s displayed release/version label was updated from Revision v3.5.2 to Revision v3.5.3, indicating a site-level version change rather than a modification to the clinical study record.
    Difference
    0.1%
    Check dated 2026-04-23T22:10:06.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Medullary Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Medullary Thyroid Cancer Clinical Trial page.